STERIS generated $5.9B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $782.4M with a 13.18% net margin. Gross margin stands at 44.25% and operating margin at 18.56%. Diluted EPS is $7.93, which grew 0.3% year-over-year. Based on the Q1 2026 filing.